Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-12-12

Clinical Trial Update: Niclosamide With Etanercept in Rheumatoid Arthritis [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating niclosamide with etanercept for rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Etanercept (etanercept)
  • Niclosamide (niclosamide)

Snippet

Sponsor: Faiq Gorial | Conditions: Rheumatoid Arthritis (RA) | Phase 1, Phase 2 | Status: COMPLETED